Galmed Pharmaceuticals Reports Full Year 2015 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Galmed Pharmaceuticals Reports Full Year 2015 Financial Results and Provides Business Update

Galmed Pharma (GLMD) Misses Q4 EPS by 1c

March 22, 2016 7:38 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More